• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道间质瘤(GISTs)中新型基因DOG1的突变检测

Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).

作者信息

Miwa Shigeharu, Nakajima Takahiko, Murai Yoshihiro, Takano Yasuo, Sugiyama Toshiro

机构信息

Department of Gastroenterology and Hematology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

出版信息

J Gastroenterol. 2008;43(7):531-7. doi: 10.1007/s00535-008-2195-4. Epub 2008 Jul 23.

DOI:10.1007/s00535-008-2195-4
PMID:18648740
Abstract

BACKGROUND

Recently, the novel gene DOG1 has been found to be overexpressed in most gastrointestinal stromal tumors (GISTs) specifically within the field of soft tissue tumors. DOG1 might play a role in development of GISTs and have potential as a diagnostic marker and therapeutic target, but the biological function and the overexpression mechanism have not yet been investigated. In this study we examined whether the DOG1 gene mutation occurs as with the KIT gene and PDGFRA gene.

METHODS

We investigated ten resected primary GIST tissues. All cases were examined for immunoreactivity for KIT and DOG1 and screened for mutation in the KIT gene (exons 9, 11, 13, and 17) and the PDGFRA gene (exons 12, 14, and 18) by direct DNA sequencing. Four cases with relatively good quality DNA were analyzed for the DOG1 gene (exons 1-26) mutation.

RESULTS

All ten GISTs showed immunoreactivity for KIT. Although all cases expressed DOG1 in immunohistochemistry, we could not find any mutations within all 26 exons (a total of 104 exons) of the DOG1 gene in the four analyzed cases.

CONCLUSIONS

Based on four cases, the DOG1 gene was found not to be mutated in GISTs.

摘要

背景

最近,发现新基因DOG1在大多数胃肠道间质瘤(GIST)中过表达,特别是在软组织肿瘤领域。DOG1可能在GIST的发生发展中起作用,并有作为诊断标志物和治疗靶点的潜力,但尚未对其生物学功能和过表达机制进行研究。在本研究中,我们检测了DOG1基因是否像KIT基因和PDGFRA基因那样发生突变。

方法

我们研究了10例手术切除的原发性GIST组织。所有病例均检测KIT和DOG1的免疫反应性,并通过直接DNA测序筛查KIT基因(第9、11、13和17外显子)和PDGFRA基因(第12、14和18外显子)的突变。对4例DNA质量相对较好的病例分析DOG1基因(第1 - 26外显子)的突变情况。

结果

所有10例GIST均显示KIT免疫反应性。虽然所有病例在免疫组织化学中均表达DOG1,但在4例分析病例的DOG1基因的所有26个外显子(共104个外显子)中均未发现任何突变。

结论

基于4例病例,发现DOG1基因在GIST中未发生突变。

相似文献

1
Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).胃肠道间质瘤(GISTs)中新型基因DOG1的突变检测
J Gastroenterol. 2008;43(7):531-7. doi: 10.1007/s00535-008-2195-4. Epub 2008 Jul 23.
2
PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.血小板衍生生长因子受体A(PDGFRA)和干细胞因子受体(KIT)突变状态及其与临床病理特征(包括DOG1)的关联。
Oncol Res. 2016;24(1):41-53. doi: 10.3727/096504016X14576297492418.
3
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.新型标志物DOG1在胃肠道间质瘤中普遍表达,与KIT或PDGFRA突变状态无关。
Am J Pathol. 2004 Jul;165(1):107-13. doi: 10.1016/S0002-9440(10)63279-8.
4
DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.DOG1 和 PKC-θ 有助于诊断 KIT 阴性胃肠道间质瘤。
Mod Pathol. 2011 Jun;24(6):866-75. doi: 10.1038/modpathol.2011.11. Epub 2011 Feb 25.
5
Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.中国人群胃肠道间质瘤中血小板衍生生长因子受体A(PDGFRA)和双拷贝基因1(DOG1)突变的存在情况。
Int J Clin Exp Pathol. 2015 May 1;8(5):5721-6. eCollection 2015.
6
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.在携带KIT或PDGFRA突变的胃肠道间质瘤中,DOG1表达与复发风险的相关性。
BMC Cancer. 2016 Feb 11;16:87. doi: 10.1186/s12885-016-2111-x.
7
Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.单克隆抗体DOG1.1在胃肠道间质瘤(包括罕见亚型)的诊断中显示出比KIT更高的敏感性。
Am J Surg Pathol. 2009 Mar;33(3):437-46. doi: 10.1097/PAS.0b013e318186b158.
8
Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.DOG1、CD117和PDGFRA在胃肠道间质瘤中的表达及其与临床病理特征的相关性
Asian Pac J Cancer Prev. 2012;13(4):1389-93. doi: 10.7314/apjcp.2012.13.4.1389.
9
DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.DOG1抗体在胃肠道间质瘤鉴别诊断中的应用:1840例病例研究
Am J Surg Pathol. 2009 Sep;33(9):1401-8. doi: 10.1097/PAS.0b013e3181a90e1a.
10
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.DOG1 调控胃肠道间质瘤的生长和 IGFBP5。
Cancer Res. 2013 Jun 15;73(12):3661-70. doi: 10.1158/0008-5472.CAN-12-3839. Epub 2013 Apr 10.

引用本文的文献

1
Contribution of Anoctamins to Cell Survival and Cell Death.anoctamins对细胞存活和细胞死亡的作用。
Cancers (Basel). 2019 Mar 19;11(3):382. doi: 10.3390/cancers11030382.
2
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.基因表达分析确定了KIT阴性胃肠道间质瘤样(KNGL)患者中的两个不同亚群。
Oncotarget. 2018 Apr 3;9(25):17576-17588. doi: 10.18632/oncotarget.24799.
3
Expression of CD117, DOG-1, and IGF-1R in gastrointestinal stromal tumours - an analysis of 70 cases from 2004 to 2010.

本文引用的文献

1
Phylogeny of the TMEM16 protein family: some members are overexpressed in cancer.跨膜蛋白16(TMEM16)蛋白家族的系统发育:某些成员在癌症中过度表达。
Int J Mol Med. 2005 Nov;16(5):919-24.
2
Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors.胃肠道间质瘤的病理生理学、诊断与治疗
J Gastroenterol. 2005 Aug;40(8):775-80. doi: 10.1007/s00535-005-1674-0.
3
A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.携带kit K641E的胃肠道间质瘤敲入小鼠模型。
2004年至2010年70例胃肠道间质瘤中CD117、DOG-1和IGF-1R的表达情况分析
Prz Gastroenterol. 2016;11(2):115-22. doi: 10.5114/pg.2015.52587. Epub 2015 Jun 24.
4
Histopathological Features of Gastrointestinal Stromal Tumors and the Contribution of DOG1 Expression to the Diagnosis.胃肠道间质瘤的组织病理学特征及DOG1表达对诊断的贡献
Balkan Med J. 2015 Oct;32(4):388-96. doi: 10.5152/balkanmedj.2015.15912. Epub 2015 Oct 1.
5
Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.中国人群胃肠道间质瘤中血小板衍生生长因子受体A(PDGFRA)和双拷贝基因1(DOG1)突变的存在情况。
Int J Clin Exp Pathol. 2015 May 1;8(5):5721-6. eCollection 2015.
6
Perineurioma in the sigmoid colon diagnosed and treated by endoscopic resection.经内镜切除诊断并治疗的乙状结肠神经束膜瘤
Clin J Gastroenterol. 2014 Oct;7(5):392-6. doi: 10.1007/s12328-014-0519-x. Epub 2014 Aug 19.
7
Therapeutic effect and mechanism of electroacupuncture at Zusanli on plasticity of interstitial cells of Cajal: a study of rat ileum.电针对 Cajal 间质细胞可塑性的治疗作用及其机制:大鼠回肠研究。
BMC Complement Altern Med. 2014 Jun 7;14:186. doi: 10.1186/1472-6882-14-186.
8
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.DOG1 调控胃肠道间质瘤的生长和 IGFBP5。
Cancer Res. 2013 Jun 15;73(12):3661-70. doi: 10.1158/0008-5472.CAN-12-3839. Epub 2013 Apr 10.
9
Chloride channels: often enigmatic, rarely predictable.氯离子通道:常神秘莫测,少能预测。
Annu Rev Physiol. 2010;72:95-121. doi: 10.1146/annurev-physiol-021909-135811.
10
Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels.anoctamin/TMEM16家族成员是钙离子激活的氯离子通道。
J Physiol. 2009 May 15;587(Pt 10):2127-39. doi: 10.1113/jphysiol.2008.163709. Epub 2008 Nov 17.
Cancer Res. 2005 Aug 1;65(15):6631-9. doi: 10.1158/0008-5472.CAN-05-0891.
4
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.KIT激酶结构域1中的错义突变与胃肠道间质瘤中的伊马替尼耐药性相关。
Cancer Res. 2004 Sep 1;64(17):5913-9. doi: 10.1158/0008-5472.CAN-04-0085.
5
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.KIT阴性胃肠道间质瘤:概念验证及治疗意义
Am J Surg Pathol. 2004 Jul;28(7):889-94. doi: 10.1097/00000478-200407000-00007.
6
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.新型标志物DOG1在胃肠道间质瘤中普遍表达,与KIT或PDGFRA突变状态无关。
Am J Pathol. 2004 Jul;165(1):107-13. doi: 10.1016/S0002-9440(10)63279-8.
7
A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients.甲磺酸伊马替尼(STI571)对日本患者胃肠道间质瘤的一项初步研究。
J Gastroenterol. 2004;39(4):329-33. doi: 10.1007/s00535-003-1298-1.
8
Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital.采用间歇微波辐射的改良1小时快速免疫染色法:基于在富山医科药科大学医院5年应用的实用性
Mod Pathol. 2004 Sep;17(9):1141-9. doi: 10.1038/modpathol.3800165.
9
Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation.转移性胃肠道间质瘤对伊马替尼治疗的晚期耐药与第二次KIT突变有关。
Br J Cancer. 2004 Jun 1;90(11):2059-61. doi: 10.1038/sj.bjc.6601819.
10
Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.KIT(CD117抗原)免疫反应阴性的胃肠道间质瘤(GISTs)
J Pathol. 2004 Apr;202(4):430-8. doi: 10.1002/path.1546.